Literature DB >> 4179761

The clinical use of diphenylhydantoin (dilantin) in the treatment and prevention of cardiac arrhythmias.

R H Helfant, G W Seuffert, R D Patton, E Stein, A N Damato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4179761     DOI： 10.1016/0002-8703(69)90187-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

1.  Procainamide and phenytoin. Comparative study of their antiarrhythmic effects at apparent therapeutic plasma levels.

Authors:  E Karlsson
Journal:  Br Heart J       Date:  1975-07

Review 2.  Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.

Authors:  D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal:  Drugs       Date:  1973       Impact factor: 9.546

3.  Efficacy of phenytoin in suppressing inducible ventricular tachyarrhythmias.

Authors:  R N Fogoros; S B Fiedler; J J Elson
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.